← Back to Clinical Trials
Recruiting NCT06330779

NCT06330779 Trauma-adapted Yoga in Child & Adolescent Psychiatry.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06330779
Status Recruiting
Phase
Sponsor University West, Sweden
Condition ADHD
Study Type INTERVENTIONAL
Enrollment 180 participants
Start Date 2025-02-01
Primary Completion 2027-12-31

Trial Parameters

Condition ADHD
Sponsor University West, Sweden
Study Type INTERVENTIONAL
Phase N/A
Enrollment 180
Sex ALL
Min Age 12 Years
Max Age 18 Years
Start Date 2025-02-01
Completion 2027-12-31
Interventions
Trauma-adapted yoga

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this randomized clinical trial is to evaluate the efficacy of trauma-adapted yoga as a complementary intervention to care as usual in child and adolescents psychiatry clinics, in the population of adolescents with the diagnosis of ADHD and/or PTSD. We hypothesize that trauma-adapted yoga (TAY) is an effective non-pharmacological intervention for adolescent with ADHD and/or PTSD. Aims: (1) Validate the impact of TAY on the mental health \& quality of life of adolescents with ADHD and/or PTSD. (2) Investigate the feasibility of online TAY for continued self-care. (3) Explore adolescents' experiences \& parental perspectives on TAY in their treatment. (4) Explore healthcare professionals' experience on the integration of TAY into clinical practice. Within and between group (yoga group vs waiting list) analyses will be performed.

Eligibility Criteria

Inclusion Criteria: * Adolescents who have received a diagnosis (not under evaluation) of PTSD and/or ADHD * Understanding English or Swedish languages. Exclusion Criteria: * Ongoing substance use, * active manic periods, * psychotic disorders, * suicidality, * cognitive impairment. * serious physical illness prohibiting participation in physical activities.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology